Sovereign Medical

The European Metabolic Review is intended to provide an in-depth analysis and overview of the Metabolic Syndrome which is commonly associated with overweight, obesity, and diabetes mellitus type 2, (DM T2). Currently available therapies are not effective enough to normalise glucose and lipid metabolism and thus prevent complications. The review will address urgent unmet needs and opportunities to improve diabetes therapy for approximately 20 million patients in Europe and. Independent articles examining the clinical features, treatment and research into the cluster of related risk factors of cardiovascular disease and diabetes mellitus type 2 characterised by abdominal obesity, abnormal blood lipid levels, high blood pressure and glucose intolerance are written and presented by leading experts in Europe